Brain Vessel Disorder Tied to Fourfold Dementia Risk in U.S. Seniors
A preliminary American Heart Association study of nearly two million U.S. Medicare beneficiaries 65 and older finds that cerebral amyloid angiopathy (CAA)—a protein buildup in brain blood vessels—was associated with about a fourfold higher risk of dementia within five years. Using 2016–2022 claims data, researchers grouped patients by CAA and stroke status and found roughly 42% of those with CAA developed dementia versus 10% without the condition, with risk remaining high even in CAA patients who had never had a stroke. Lead author Dr. Samuel S. Bruce of Weill Cornell Medicine said dementia risk was similar in people with CAA regardless of stroke history, and higher than in those with stroke alone, suggesting the vascular protein deposits independently damage brain function. The work, to be presented at the American Stroke Association’s International Stroke Conference in New Orleans, relies on diagnostic codes rather than imaging and has not yet been peer‑reviewed, but it highlights the need for proactive cognitive screening and risk‑factor control in older adults diagnosed with CAA. Experts note that millions of Americans over 50 may have moderate to severe CAA, meaning better detection and management could have significant implications for dementia prevention and care planning.
📌 Key Facts
- Study examined nearly 2 million U.S. adults 65+ with Medicare coverage, following them from 2016 to 2022 for new dementia diagnoses.
- About 42% of people with cerebral amyloid angiopathy were diagnosed with dementia within five years, compared with roughly 10% of those without CAA.
- Elevated dementia risk in CAA patients was similar whether or not they had a history of stroke, and higher than in those with stroke alone.
📰 Source Timeline (1)
Follow how coverage of this story developed over time